Ari Cohen
Surgery · New Orleans, LANPI 1144286436
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,400 of the $28,270 with a category attached, or 93.4%. Boston Scientific accounts for 97.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $25,246 and has fallen 99.2% since, to $207 in 2025. Among surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $911.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$27K
- Fujifilm Healthcare Americas Corporation$329
- Sanofi$295
- Organox Ltd$112
- Conmed Corporation$72
- Sanofi-aventis U.S. LLC$24
- plus $6 from 1 others
Across 9 payments — averaging $41,969 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$378K
What the payments were for
- Speaking & faculty fees$26,40093%
- Travel & lodging$4702%
- Food & beverage$1,3945%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $27,432 |
| Fujifilm Healthcare Americas Corporation | 4 | $329 |
| Sanofi | 3 | $295 |
| Organox Ltd | 3 | $112 |
| Conmed Corporation | 1 | $72 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Veloxis Pharmaceuticals, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,270 in reported general payments places this provider in the 90th percentile of 381 surgery providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 37 | $6,287 |
| Tacrolimus | 17 | $2,274 |
| Ursodiol | 11 | $489 |
| Mirtazapine | 15 | $332 |
| Nifedipine ErNifedipine | 12 | $197 |
| Gabapentin | 18 | $177 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 50 | $172 |
| Venlafaxine Hcl | 11 | $145 |
| Pantoprazole Sodium | 20 | $88 |
| Carvedilol | 12 | $80 |
| Atorvastatin Calcium | 11 | $68 |
| Famotidine | 14 | $58 |
| Furosemide | 14 | $53 |
| Methocarbamol | 12 | $45 |
| Trazodone Hcl | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgery in New Orleans
- Carlos GalvaniNew Orleans$352K
- Joseph BuellNew Orleans$186K
- Michael CookNew Orleans$84K
- Douglas SlakeyNew Orleans$81K
- Ian HodgdonNew Orleans$38K
- Shauna LevyNew Orleans$33K
- Adwoa Opoku-BoatengNew Orleans$30K
- Mohamed-Aly BakeerNew Orleans$27K
- William KethmanNew Orleans$27K
- Jacquelyn TurnerNew Orleans$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.